BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9469331)

  • 1. Skin recurrences after breast-conserving therapy for early-stage breast cancer.
    Gage I; Schnitt SJ; Recht A; Abner A; Come S; Shulman LN; Monson JM; Silver B; Harris JR; Connolly JL
    J Clin Oncol; 1998 Feb; 16(2):480-6. PubMed ID: 9469331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome following breast-conserving surgery and radiation therapy.
    Gage I; Recht A; Gelman R; Nixon AJ; Silver B; Bornstein BA; Harris JR
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):245-51. PubMed ID: 7673011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
    Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
    J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
    Bartelink H; Horiot JC; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Borger J; Jager J; Hoogenraad W; Collette L; Pierart M;
    N Engl J Med; 2001 Nov; 345(19):1378-87. PubMed ID: 11794170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications.
    Haffty BG; Goldberg NB; Fischer D; McKhann C; Beinfield M; Weissberg JB; Carter D; Gerald W
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):727-32. PubMed ID: 2777662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.
    Wilkinson JB; Vicini FA; Shah C; Shaitelman S; Jawad MS; Ye H; Kestin LL; Goldstein NS; Martinez AA; Benitez P; Chen PY
    Ann Surg Oncol; 2012 Nov; 19(12):3785-91. PubMed ID: 22644510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E; Buchholz TA; Meric F; Krishnamurthy S; Mirza NQ; Ames FC; Feig BW; Kuerer HM; Ross MI; Singletary SE; McNeese MD; Strom EA; Hunt KK
    Cancer; 2002 Nov; 95(10):2059-67. PubMed ID: 12412158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic multifocality is predictive of skin recurrences after conserving treatment of stage I and II breast cancers.
    Marret H; Perrotin F; Bougnoux P; Giraudeau B; Hubert B; Fetissof F; Le Floch O; Lansac J; Body G
    Breast Cancer Res Treat; 2001 Jul; 68(1):1-8. PubMed ID: 11678304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
    Cutuli B; Lemanski C; Le Blanc-Onfroy M; de Lafontan B; Cohen-Solal-Le-Nir C; Fondrinier E; Mignotte H; Giard S; Charra-Brunaud C; Auvray H; Gonzague-Casabianca L; Quétin P; Fay R
    Cancer Radiother; 2013 Jun; 17(3):196-201. PubMed ID: 23538041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
    Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second breast-conserving surgery and interstitial brachytherapy vs. salvage mastectomy for the treatment of local recurrences: 5-year results.
    Smanykó V; Mészáros N; Újhelyi M; Fröhlich G; Stelczer G; Major T; Mátrai Z; Polgár C
    Brachytherapy; 2019; 18(3):411-419. PubMed ID: 30890318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy.
    Zhou P; Gautam S; Recht A
    Breast Cancer Res Treat; 2007 Jan; 101(1):51-7. PubMed ID: 16821084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
    Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
    Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.